The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of ...
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
and Boehringer Ingelheim and Eli Lilly’s Type 2 diabetes drug Jardiance, the last of which previously took the seventh spot on this list in October. All together, drugmakers threw $274.4 million ...
BOGOTÁ, Colombia — One of Colombia’s legendary drug lords and a key operator of the Medellin cartel has been deported back to the South American country, after serving 25 years of a 30-year ...
Dec 23 (Reuters) - The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' (HIK.L), opens new tab generic version of Novo Nordisk's diabetes drug (NOVOb.CO), opens new tab ...
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...
Your browser does not support the audio element. JSW MG Motor India has officially revealed key details about its highly anticipated Cyberster electric sportscar ...
Those who have commercial drug insurance may qualify to pay as low as $25 for a one to three-month supply of Zepbound. For those whose commercial drug insurance does not cover Zepbound ...
with the U.S. Food and Drug Administration (FDA). However, BCVA data across all study timepoints demonstrated an improvement in vision, increasing over time, and the presence of biologic activity.